Medicinal products for human use
Good Manufacturing Practices for Advanced Therapies: Commission adopts new Guidelines |
The new Guidelines adapt the GMP requirements to the specific characteristics of ATMPs and address novel scenarios such as decentralised manufacturing, automated production, and reconstitution of ATMPs. |
Go to related site |
Medicinal products for human use
Version 8 of the "Questions and Answers" document regarding the implementation of the rules on the safety features for medicinal products for human use Go to related site
Scientific Committees
SCHEER - Minutes of the Working Group Meeting on Weight of Evidence and uncertainties of 9 November 2017 Get this document